You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Triple Negative Disease

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Triple Negative Breast Tumors Trial (Pembrolizumab injection, Capecitabine tablets, Local radiotherapy)

Not yet recruiting
  • Triple Negative Breast Neoplasms
  • Pembrolizumab injection
  • +2 more
  • (no location specified)
Jul 25, 2023

Triple Negative Breast Cancer, Residual Disease Trial (Tetrathiomolybdate, Capecitabine, Pembrolizumab)

Not yet recruiting
  • Triple Negative Breast Cancer
  • Residual Disease
  • (no location specified)
Nov 15, 2023

Edema, Erythema, Estrogen Receptor Negative Trial in Houston (Laboratory Biomarker Analysis, Pembrolizumab)

Active, not recruiting
  • Edema
  • +8 more
  • Laboratory Biomarker Analysis
  • Pembrolizumab
  • Houston, Texas
    M D Anderson Cancer Center
Jan 23, 2023

Breast, Metastatic, Triple Negative Trial in Gainesville, Jacksonville (Capecitabine, Sarilumab 150mg or 200 mg plus

Active, not recruiting
  • Breast
  • +4 more
  • Gainesville, Florida
  • +1 more
Feb 2, 2023

Leptomeningeal Disease, Triple Negative Breast Cancer, HER2-positive Breast Cancer Trial in Tampa (Dendritic Cell Vaccine)

Recruiting
  • Leptomeningeal Disease
  • +2 more
  • Dendritic Cell Vaccine
  • Tampa, Florida
    Moffitt Cancer Center
Apr 11, 2023

Triple Negative Breast Cancer Trial in United States (Sacituzumab govitecan-hziy (SG), Pembrolizumab, Capecitabine)

Recruiting
  • Triple Negative Breast Cancer
  • Sacituzumab govitecan-hziy (SG)
  • +2 more
  • Glendale, Arizona
  • +7 more
Jan 26, 2023

Hepatocellular Carcinoma, Pancreatic Ductal Adenocarcinoma, Biliary Tract Cancers Trial (ABBV-400)

Not yet recruiting
  • Hepatocellular Carcinoma
  • +6 more
  • (no location specified)
Oct 10, 2023

Breast Cancer, Triple Negative Breast Tumors Trial in France (Nivolumab, Ipilimumab, Capecitabine)

Active, not recruiting
  • Breast Cancer
  • Triple Negative Breast Neoplasms
  • Angers, France
  • +16 more
Jul 21, 2022

Triple Negative Breast Cancer, Breast Cancer Trial in Stanford (Capecitabine)

Recruiting
  • Triple Negative Breast Cancer
  • Breast Cancer
  • Stanford, California
    Stanford University
Jan 7, 2022

Triple Negative Breast Cancer, Residual Disease Trial in Boston (Niraparib, Radiation Therapy)

Recruiting
  • Triple Negative Breast Cancer
  • Residual Disease
  • Boston, Massachusetts
  • +1 more
Oct 27, 2021

Blood Cytokine Values in Breast Cancers.

Completed
  • Breast Cancer
  • Flow-Cytometric analysis
  • Istanbul, Turkey
    Istanbul Training and Research Hospital
Aug 8, 2022

Triple Negative Breast Cancer Trial in Washington, Chicago, Hackensack (Nivolumab, Capecitabine)

Active, not recruiting
  • Triple Negative Breast Cancer
  • Washington, District of Columbia
  • +3 more
Mar 14, 2022

Breast Cancer, Triple Negative Breast Cancer Trial in Houston, Sugar Land (Everolimus)

Completed
Has Results
  • Breast Cancer
  • Triple Negative Breast Cancer
  • Houston, Texas
  • +2 more
Jul 16, 2021

TNBC - Triple-Negative Breast Cancer, Triple Negative Breast Cancer, NSCLC Trial in United States (Sterotactic Body

Active, not recruiting
  • TNBC - Triple-Negative Breast Cancer
  • +6 more
  • Sterotactic Body Radiotherapy/SBRT
  • Standard of care
  • Basking Ridge, New Jersey
  • +8 more
Jul 26, 2022

Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Triple Negative Breast Cancer Trial in United States

Recruiting
  • Non Small Cell Lung Cancer
  • +11 more
  • Denver, Colorado
  • +3 more
Jan 10, 2023

TNBC - Triple-Negative Breast Cancer Trial in Wuhan (Utidelone, Tirelizumab, Bevacizumab)

Recruiting
  • TNBC - Triple-Negative Breast Cancer
  • Wuhan, Hubei, China
    Tongji Hospital Affiliated of Tongji Medical College Huazhong Un
Nov 5, 2023

Triple Negative Breast Cancer Trial (Sacituzumab govitecan, Pembrolizumab)

Not yet recruiting
  • Triple Negative Breast Cancer
  • (no location specified)
Oct 5, 2023

Immunotherapy-related CRP Kinetics in Early and Metastatic

Recruiting
  • TNBC - Triple-Negative Breast Cancer
    • Tuebingen, Germany
      Department of Women's Health
    Jun 13, 2023

    Triple Negative Breast Cancer Trial (Proleukin 1.3 MG Injection)

    Not yet recruiting
    • Triple Negative Breast Cancer
    • Proleukin 1.3 MG Injection
    • (no location specified)
    Apr 6, 2023

    Metastatic Triple-Negative Breast Cancer Trial in Charlotte (Trilaciclib, Pembrolizumab, Gemcitabine)

    Not yet recruiting
    • Metastatic Triple-Negative Breast Cancer
    • Charlotte, North Carolina
      Levine Cancer Institute
    Aug 31, 2023

    Breast Cancer, Triple Negative Breast Cancer Trial (Antivascular therapy, Chemotherapy)

    Not yet recruiting
    • Breast Cancer
    • Triple Negative Breast Cancer
    • (no location specified)
    Jun 11, 2023

    BRCA1 Hereditary Breast and Ovarian Cancer Syndrome Trial in Barretos (Doxorubicin, Carboplatin, Paclitaxel)

    Completed
    • BRCA1 Hereditary Breast and Ovarian Cancer Syndrome
    • Barretos, SP, Brazil
      Barretos Cancer Hospital
    Dec 25, 2022

    Triple Negative Breast Cancer, Metastatic Breast Cancer, Mutation Trial in Shanghai (Everolimus, Investigator's Choice of

    Not yet recruiting
    • Triple Negative Breast Cancer
    • +2 more
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Jul 25, 2023

    TNBC - Triple-Negative Breast Cancer Trial (Camrelizumab Plus Chemotherapy and Famitinib, Camrelizumab Plus Chemotherapy)

    Not yet recruiting
    • TNBC - Triple-Negative Breast Cancer
    • Camrelizumab Plus Chemotherapy and Famitinib
    • Camrelizumab Plus Chemotherapy
    • (no location specified)
    Aug 17, 2023

    Triple Negative Breast Tumors Trial in Paris (Atezolizumab + RP1)

    Not yet recruiting
    • Triple Negative Breast Neoplasms
    • Atezolizumab + RP1
    • Paris, France
      Institut Curie
    Oct 2, 2023